People with type 2 diabetes (T2D) and chronic kidney disease (CKD) are at high risk for cardiovascular (CV) events, including CV death, myocardial infarction (MI), and stroke, as well as death due to any cause.1 The high risk for CV events and mortality is strongly correlated with the severity of CKD, defined by estimated glomerular filtration rate (eGFR), urine albumin-to-creatinine ratio (UACR), or Kidney Disease Improving Global Outcomes (KDIGO) risk classification using both eGFR and UACR.2–5. The gene discussed is ALB; the disease is type 2 diabetes mellitus.